Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Current Assets Current Deferred Revenue Current Taxes Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables Receivables - Net Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Treasury Shares

Cash Flow Statement

Daily Values

Growth Metrics

Celularity (CELU) Preferred Stock Liabilities (2020 - 2021)

Celularity (CELU) has disclosed Preferred Stock Liabilities for 2 consecutive years, with $290.9 million as the latest value for Q2 2021.

For Q2 2021, Preferred Stock Liabilities rose 57.87% year-over-year to $290.9 million; the TTM value through Jun 2021 reached $290.9 million, up 57.87%, while the annual FY2020 figure was $290.9 million, N/A changed from the prior year.
Preferred Stock Liabilities hit $290.9 million in Q2 2021 for Celularity, up from $75.0 million in the prior quarter.
Across five years, Preferred Stock Liabilities topped out at $290.9 million in Q4 2020 and bottomed at $75.0 million in Q1 2020.